Eczematous Skin Diseases

Subscribe to Selected New Research on Eczematous Skin Diseases

15 relevant articles (1 outcomes, 0 trials/studies) found for this Disease

Description: Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.

Also Known As:

Skin Diseases, Eczematous; Eczematous Disorders; Disease, Eczematous Skin; Diseases, Eczematous Skin; Disorder, Eczematous; Disorders, Eczematous; Eczematous Disorder; Eczematous Skin Disease; Skin Disease, Eczematous

Relationship Network

Disease Context: Research Results

Skin and Connective Tissue Diseases

Skin Diseases: 5932

Eczematous Skin Diseases: 15

Atopic Dermatitis: 4913

Contact Dermatitis: 4393

Eczema: 2387

Exfoliative Dermatitis: 552

Seborrheic Dermatitis: 329

Neurodermatitis: 232

Intertrigo: 30

Related Diseases

1.	Skin Diseases
2.	Atopic Dermatitis (Atopic Eczema)
3.	Lymphomatoid Papulosis
4.	Xeroderma Pigmentosum (Kaposi's Disease)
5.	Urticaria (Hives)
15 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Eczematous Skin Diseases:

1.	Adrenal Cortex Hormones (Corticosteroids)IBA 01/01/2006 - "Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids" 04/01/1997 - "Bufexamac-containing ointments and creams are widely used by many patients with eczematous disorders as an alternative to topical corticosteroids" Get all the results and reference details, order at left...
2.	methylprednisolone aceponateIBA 01/01/2006 - "Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids" Get all the results and reference details, order at left...
3.	Immunoglobulin E (IgE)IBA 01/01/1991 - "Atopic dermatitis (AD) is a severe and chronic eczematous skin disease, to which increased IgE levels and imbalances of CD4+ T cells are related" 11/01/1994 - "BACKGROUND AND DESIGN: Atopic dermatitis (AD) is a chronic eczematous skin disease that develops in a patient with atopic diathesis, which is characterized by an increased liability to produce IgE antibodies for environmental allergens mostly derived from other living organisms" Get all the results and reference details, order at left...
4.	AllergensIBA 08/01/2000 - "Reactions to contact allergens and aeroallergens were detected using patch testing and intradermal testing, respectively, with non-facial eczematous skin disease patients serving as controls" 11/01/1994 - "BACKGROUND AND DESIGN: Atopic dermatitis (AD) is a chronic eczematous skin disease that develops in a patient with atopic diathesis, which is characterized by an increased liability to produce IgE antibodies for environmental allergens mostly derived from other living organisms" Get all the results and reference details, order at left...
5.	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/01/1998 - "Cyclosporine is efficacious in short-term treatment of various eczematous disorders" Get all the results and reference details, order at left...
6.	Tacrolimus (Prograf)FDA Link 02/01/2001 - "CONCLUSION: Tacrolimus can exert immunopharmacologic alterations on LCs, which may account, at least in part, for the therapeutic effect of this compound in eczematous skin diseases." Get all the results and reference details, order at left...
7.	Interleukin-2 Receptors (IL 2 Receptor)IBA 02/01/1990 - "Soluble IL-2 receptors were studied in 184 patients affected by skin diseases: eczematous dermatitis, lichen, psoriasis, erythroderma psoriaticum, dermatomyositis, scleroderma bullous dermatosis, melanoma, Kaposi's disease, lymphomatoid papulosis, non-Hodgkin lymphoma, mycosis fungoides (MF), Sezary's syndrome (SS)" Get all the results and reference details, order at left...
8.	Urea (Carbamide)FDA LinkGeneric 07/01/1981 - "Patch tests with a cream (Calmuril) containing 10% urea were performed on 79 patients with eczematous skin disease; seven (9.9%) had positive tests" Get all the results and reference details, order at left...
9.	Ointments (Pastes)IBA 04/01/1997 - "Bufexamac-containing ointments and creams are widely used by many patients with eczematous disorders as an alternative to topical corticosteroids" Get all the results and reference details, order at left...
10.	NickelIBA 01/01/1984 - "Among allergic nickel-induced conditions, eczematous skin diseases predominate" Get all the results and reference details, order at left...
20 Drugs and Important Bio-Agents and 15 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>